by Chris Wasden | Nov 12, 2018 | Digital Health, Digital therapeutics, Innovation
I recently attended the CNS Summit in Boca Raton, Florida to learn more about what digital therapeutics and pharmaceutical companies are doing in their collaborations together. I came away with a new insight I wanted to share. Pear Therapeutics and Novartis have...
by Chris Wasden | Oct 3, 2018 | Digital Health, Digital therapeutics, Innovation
Mental maps guide our behaviors. Without them we can’t act. When ever we face a need to act based upon a specific context, we pull out the appropriate map, we then recruit an identity, create some emotions, and then act. For example, if we arrive at a football game,...
by Chris Wasden | Aug 20, 2018 | Digital Health, Digital therapeutics, Innovation
This is part-two to my blog post on my interview with Adrian Chernoff where I asked him how big pharma should think about innovating in the digital space. Click here to read the first part: 3 Reason Why Big Pharma Can’t Charge A Premium for Drug+ Digital? Having...
by Chris Wasden | Aug 13, 2018 | Digital Health, Digital therapeutics, Innovation
The other day I met with Adrian Chernoff to discuss what type of business models digital health and therapeutic companies should be exploring and how they should think about getting paid for innovating beyond the molecule. Digital health has emerged as the term to...
by Chris Wasden | Aug 6, 2018 | Innovation
Imagine you have a job that you think will safely, securely, and simply take you to retirement as long as you just hang in there. You think you are reasonably happy at work, despite the usual hassles and bureaucracy we all must endure. Then one day, your boss calls...
